[Regulatory T-cells and their role in antitumor immune response].
Kadagidze
Z G
ZG
Chertkova
A I
AI
Slavina
E G
EG
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D014408:Biomarkers, Tumor / Q000097:blood; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004167:Diphtheria Toxin / Q000494:pharmacology; D051858:Forkhead Transcription Factors / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D053645:Interleukin-2 Receptor alpha Subunit / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D004167:Diphtheria Toxin; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; C500522:Foxp3 protein, rat; D007376:Interleukin-2; D053645:Interleukin-2 Receptor alpha Subunit; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox